Anti-HLA antibodies after solid organ transplantation

被引：294

作者：

McKenna, RM

Takemoto, SK

Terasaki, PI

机构：

[1] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 4N1, Canada

[2] Calgary Lab Serv, Calgary, AB T2N 4N1, Canada

[3] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA

来源：

TRANSPLANTATION | 2000年 / 69卷 / 03期

关键词：

D O I：

10.1097/00007890-200002150-00001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：319 / 326

页数：8

共 57 条

[31] Vascular rejection post heart transplantation is associated with positive flow cytometric cross-matching [J].

McCarthy, JF ;

Cook, DJ ;

Massad, MG ;

Sano, Y ;

O'Malley, KJ ;

Ratliff, NR ;

Stewart, RW ;

Smedira, NG ;

Starling, RC ;

Young, JB ;

McCarthy, P .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1998, 14 (02) :197-200

[32] Identification of patients at high risk of graft loss by pre- and posttransplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay [J].

Monteiro, F ;

Buelow, R ;

Mineiro, C ;

Rodrigues, H ;

Kalil, J .

TRANSPLANTATION, 1997, 63 (04) :542-546

[33] ALLOANTIBODIES AGAINST DONOR EPIDERMIS AND EARLY KIDNEY-TRANSPLANT REJECTION [J].

MORAES, JR ;

MORAES, ME ;

LUO, Y ;

STASTNY, P .

TRANSPLANTATION, 1991, 51 (02) :370-373

[34] SEROTYPING FOR HOMOTRANSPLANTATION .22. SPECIFICITY OF CYTOTOXIC ANTIBODIES DEVELOPING AFTER RENAL TRANSPLANTATION [J].

MORRIS, PJ ;

MICKEY, MR ;

SINGAL, DP ;

TERASAKI, PI .

BRITISH MEDICAL JOURNAL, 1969, 1 (5646) :758-&

[35] SIGNIFICANCE OF POSITIVE CROSSMATCH TEST IN KIDNEY TRANSPLANTATION [J].

PATEL, R ;

TERASAKI, PI .

NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (14) :735-&

[36] Simultaneous HLA class I and class II antibodies screening with flow cytometry [J].

Pei, R ;

Wang, G ;

Tarsitani, C ;

Rojo, S ;

Chen, T ;

Takemura, S ;

Liu, A ;

Lee, J .

HUMAN IMMUNOLOGY, 1998, 59 (05) :313-322

[37] Flow cytometry crossmatch: A sensitive technique for assessment of acute rejection in renal transplantation [J].

Piazza, A ;

Adorno, D ;

Poggi, E ;

Borrelli, L ;

Buonomo, O ;

Pisani, F ;

Valeri, M ;

Torlone, N ;

Camplone, C ;

Monaco, PI ;

Fraboni, D ;

Casciani, CU .

TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) :1769-1771

[38] IGG ANTIBODIES AGAINST AN HLA-ANTIGEN ARE ASSOCIATED WITH ACTIVATED CYTOTOXIC T-CELLS AGAINST THIS ANTIGEN, IGM ARE NOT [J].

ROELEN, DL ;

VANBREE, FPMJ ;

WITVLIET, MD ;

HABRAKEN, I ;

VANBEELEN, E ;

VANTSANT, PH ;

DEWAAL, LP ;

VANROOD, JJ ;

CLAAS, FHJ .

TRANSPLANTATION, 1994, 57 (09) :1388-1392

[39] Recommendations of the expert panel on ethical issues in clinical trials of transplant tolerance [J].

Rose, SM ;

Blustein, N ;

Rotrosen, D .

TRANSPLANTATION, 1998, 66 (09) :1123-1125

[40] PRETRANSPLANT AND POSTTRANSPLANT ANTIBODIES IN HUMAN CORNEAL TRANSPLANTATION [J].

ROY, R ;

BOISJOLY, HM ;

WAGNER, E ;

LANGLOIS, A ;

BERNARD, PM ;

BAZIN, R ;

LAUGHREA, PA ;

DUBE, I .

TRANSPLANTATION, 1992, 54 (03) :463-467

← 1 2 3 4 5 6 →